Glioblastoma, an opportunity T cell trafficking could bring for the treatment.

The present review summarizes the recent advances in CAR T-cell-based treatments in GBM and discusses why this approach could be positioned as a pillar of the next-generation of immunotherapies for this type of brain tumor.